Hypertonic saline for non-cystic fibrosis bronchiectasis
Part of Lungs & breathing clinical trials.
This trial tests whether inhaling a saltwater solution (hypertonic saline) twice a day for 12 weeks can help people with bronchiectasis who have a chronic cough and have had flare-ups in the past. It aims to see if this treatment reduces mucus and improves quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults 18 years or older with bronchiectasis (widened airways) confirmed by CT scan, affecting at least 2 lung sections
- Lung function (FEV1) must be more than 40% of predicted for your age and size
- Have had at least one bronchiectasis flare-up that required antibiotics in the past
- Have a daily cough that has lasted a long time
- Must not have cystic fibrosis, primary ciliary dyskinesia, or other specific lung conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether breathing salt water vapor through a home nebulizer machine helps people with a specific type of lung infection (nontuberculous mycobacteria). The goal is to see if this simple treatment can improve breathing and reduce symptoms.
This study tests how safe an experimental inhaled medicine (HSK31858) is for people with non-cystic fibrosis bronchiectasis, a lung condition where airways are damaged and collect mucus. You can only join if you already completed a previous HSK31858 study.
This trial tests an inhaled medication called CSL787 to see if it can help people with non-cystic fibrosis bronchiectasis (a lung condition that causes frequent infections and breathing problems). The study looks at different doses and checks how well the drug works and if it is safe.
This trial tests a new medicine, HSK31858, for people with non-cystic fibrosis bronchiectasis (a lung condition causing chronic cough and infections). It aims to see if the drug reduces lung flare-ups and improves symptoms.
This trial tests a home-use device called BiWaze Clear, which helps clear mucus from your lungs. It is for people with bronchiectasis (including those with cystic fibrosis) who have had recent lung infections and can use the device at home.
This study tests whether a saltwater mist (hypertonic saline) can help clear mucus from the lungs in adults with primary ciliary dyskinesia (PCD). If it works, it could improve lung function and make breathing easier.
Hear when a new Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.